Lecco, Italy

Chiara Bertarelli

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignees: Charité – Universitätsmedizin Berlin, Fondazione Istituto Italiano Di Tecnologia. Active years: 2022.


% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chiara Bertarelli: Innovator in Photochromic Compounds

Introduction

Chiara Bertarelli is a notable inventor based in Lecco, Italy. She has made significant contributions to the field of eye disorder treatments through her innovative research and development of photochromic compounds. Her work has the potential to enhance medical applications and improve patient outcomes.

Latest Patents

Chiara holds a patent for "Photochromic compounds for use in the treatment of eye disorders." This patent describes compounds with a specific formula wherein Y and Z can be independently O, N, or P. The compounds may also include optionally substituted C-Calkyl, O, or R, and can form a 3-14 membered ring. Additionally, these compounds may contain one or more heteroatoms selected from O, N, and S, which can also be optionally substituted. The compositions include such compounds, and the medical uses utilize these innovative compounds.

Career Highlights

Throughout her career, Chiara has worked with esteemed institutions such as the Fondazione Istituto Italiano Di Tecnologia and Charité – Universitätsmedizin Berlin. Her experience in these organizations has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Chiara has collaborated with notable colleagues, including Guglielmo Lanzani and Francesco Lodola. These partnerships have further enriched her research and development efforts in the area of photochromic compounds.

Conclusion

Chiara Bertarelli is a pioneering inventor whose work in photochromic compounds is paving the way for advancements in the treatment of eye disorders. Her contributions to the field are invaluable and demonstrate her commitment to innovation and improving healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…